 CAMBRIDGE, Mass.--BUSINESS WIRE--Seres Therapeutics, Inc. Nasdaq: MCRB, a leading microbiome therapeutics company, announced today that it will present the latest research from its early stage clinical development programs in two presentations at the American Society of Clinical Oncology ASCO Annual Meeting, taking place virtually from June 4-8, 2021. In an oral presentation, Seres will share data from its collaboration with the University of Cologne Köln, Germany assessing the associat 